Feb 29 |
Why Earnings Season Could Be Great for Stoke Therapeutics (STOK)
|
Feb 28 |
Analysts Estimate Zymeworks Inc. (ZYME) to Report a Decline in Earnings: What to Look Out for
|
Jan 17 |
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
|
Jan 8 |
Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024
|
Jan 4 |
Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
Dec 14 |
Wall Street Analysts Predict a 220.81% Upside in Stoke Therapeutics, Inc. (STOK): Here's What You Should Know
|
Nov 7 |
Stoke Therapeutics GAAP EPS of -$0.55 beats by $0.09, revenue of $3.31M beats by $0.24M
|
Nov 7 |
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
|